ArticleCell reports2018

Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells.

Katherine Sullivan-Reed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.